$PDFS
PDF SOLUTIONS INC

2020 Q1 Form 10-Q Financial Statement

#000143774920009856 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $21.16M $20.54M $19.73M
YoY Change 3.0% -16.96% -26.33%
Cost Of Revenue $8.487M $7.867M $9.721M
YoY Change 7.88% -31.48% -20.84%
Gross Profit $12.67M $12.67M $10.00M
YoY Change -0.02% -4.38% -30.98%
Gross Profit Margin 59.89% 61.7% 50.72%
Selling, General & Admin $7.895M $7.011M $6.130M
YoY Change 12.61% 9.98% 3.72%
% of Gross Profit 62.31% 55.32% 61.28%
Research & Development $8.590M $8.246M $6.900M
YoY Change 4.17% 13.82% -9.8%
% of Gross Profit 67.79% 65.06% 68.97%
Depreciation & Amortization $1.667M $1.292M $1.530M
YoY Change 29.02% 2.46% 2.68%
% of Gross Profit 13.16% 10.19% 15.29%
Operating Expenses $16.49M $15.46M $13.14M
YoY Change 6.65% 12.59% -3.81%
Operating Profit -$3.814M -$2.783M -$3.136M
YoY Change 37.05% 487.13% -475.57%
Interest Expense -$20.00K -$10.00K $210.0K
YoY Change 100.0% -96.97% 425.0%
% of Operating Profit
Other Income/Expense, Net -$20.00K -$6.000K
YoY Change 233.33% -98.19%
Pretax Income -$4.007M -$2.789M -$3.500M
YoY Change 43.67% 246.46% -497.73%
Income Tax -$3.500M -$98.00K -$390.0K
% Of Pretax Income
Net Earnings -$528.0K -$2.691M -$3.114M
YoY Change -80.38% 534.67% 18.22%
Net Earnings / Revenue -2.5% -13.1% -15.79%
Basic Earnings Per Share -$0.02 -$0.08 -$0.10
Diluted Earnings Per Share -$0.02 -$0.08 -$0.10
COMMON SHARES
Basic Shares Outstanding 32.70M 32.49M
Diluted Shares Outstanding 32.70M 32.49M

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.4M $90.40M $96.10M
YoY Change 11.06% -8.22% -5.13%
Cash & Equivalents $100.4M $90.42M $96.09M
Short-Term Investments
Other Short-Term Assets $10.20M $6.400M $9.600M
YoY Change 59.38% -34.02% 88.24%
Inventory
Prepaid Expenses
Receivables $37.36M $53.21M $51.57M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $149.4M $153.5M $157.2M
YoY Change -2.68% -7.88% -4.08%
LONG-TERM ASSETS
Property, Plant & Equipment $41.01M $35.94M $35.68M
YoY Change 14.12% 35.42% 40.55%
Goodwill $2.293M $1.923M $2.293M
YoY Change 19.24% 0.0% 19.24%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.322M $7.088M $6.972M
YoY Change 17.41% -27.32% -33.88%
Total Long-Term Assets $89.98M $79.20M $68.68M
YoY Change 13.62% 32.15% 13.95%
TOTAL ASSETS
Total Short-Term Assets $149.4M $153.5M $157.2M
Total Long-Term Assets $89.98M $79.20M $68.68M
Total Assets $239.4M $232.7M $225.9M
YoY Change 2.87% 2.71% 0.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.828M $2.522M $2.454M
YoY Change 91.44% -2.55% -3.23%
Accrued Expenses $1.406M $2.801M $3.235M
YoY Change -49.8% 30.22% 23.14%
Deferred Revenue $12.33M $9.220M $8.477M
YoY Change 33.69% 8.8% 6.21%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $27.06M $22.24M $19.53M
YoY Change 21.68% 20.23% -0.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.80M $734.0K $2.831M
YoY Change 1780.11% -34.58% 24.77%
Total Long-Term Liabilities $13.80M $734.0K $2.831M
YoY Change 1780.11% -34.58% 24.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.06M $22.24M $19.53M
Total Long-Term Liabilities $13.80M $734.0K $2.831M
Total Liabilities $40.89M $35.34M $26.11M
YoY Change 15.71% 44.35% 1.17%
SHAREHOLDERS EQUITY
Retained Earnings -$36.40M -$33.14M -$30.45M
YoY Change 9.82% 43.1% 12.41%
Common Stock $5.000K $5.000K $5.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $93.17M $83.62M $79.14M
YoY Change 11.43% 9.34% 10.24%
Treasury Stock Shares $9.387M $8.663K $8.295M
Shareholders Equity $198.5M $197.3M $199.8M
YoY Change
Total Liabilities & Shareholders Equity $239.4M $232.7M $225.9M
YoY Change 2.87% 2.71% 0.77%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$528.0K -$2.691M -$3.114M
YoY Change -80.38% 534.67% 18.22%
Depreciation, Depletion And Amortization $1.667M $1.292M $1.530M
YoY Change 29.02% 2.46% 2.68%
Cash From Operating Activities $5.380M -$151.0K $4.300M
YoY Change -3662.91% -104.64% 0.23%
INVESTING ACTIVITIES
Capital Expenditures $2.068M $2.357M -$4.370M
YoY Change -12.26% -3.68% 31.63%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.068M -$2.357M -$4.370M
YoY Change -12.26% -3.68% 31.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $3.917M
YoY Change -100.0% -5.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$507.0K -3.174M -540.0K
YoY Change -84.03% -12.66% 1.89%
NET CHANGE
Cash From Operating Activities $5.380M -151.0K 4.300M
Cash From Investing Activities -$2.068M -2.357M -4.370M
Cash From Financing Activities -$507.0K -3.174M -540.0K
Net Change In Cash $2.780M -5.682M -610.0K
YoY Change -148.93% 100.85% -238.64%
FREE CASH FLOW
Cash From Operating Activities $5.380M -$151.0K $4.300M
Capital Expenditures $2.068M $2.357M -$4.370M
Free Cash Flow $3.312M -$2.508M $8.670M
YoY Change -232.06% -411.55% 13.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32795326
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00015 par value
CY2020Q1 pdfs Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
317000
CY2019Q1 pdfs Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
252000
CY2020Q1 pdfs Amortization Of Other Acquired Intangibleassets
AmortizationOfOtherAcquiredIntangibleassets
173000
CY2019Q1 pdfs Amortization Of Other Acquired Intangibleassets
AmortizationOfOtherAcquiredIntangibleassets
108000
CY2020Q1 pdfs Contract With Customer Liability Billings In Excess Of Revenue Recognized
ContractWithCustomerLiabilityBillingsInExcessOfRevenueRecognized
1796000
CY2019Q4 pdfs Contract With Customer Liability Billings In Excess Of Revenue Recognized
ContractWithCustomerLiabilityBillingsInExcessOfRevenueRecognized
1117000
CY2020Q1 pdfs Increase Decrease Contract With Customer Liability Revenue Recognized
IncreaseDecreaseContractWithCustomerLiabilityRevenueRecognized
679000
CY2019Q1 pdfs Increase Decrease Contract With Customer Liability Revenue Recognized
IncreaseDecreaseContractWithCustomerLiabilityRevenueRecognized
894000
CY2020Q1 pdfs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-280000
CY2019Q1 pdfs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-166000
CY2020Q1 pdfs Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-241000
CY2019Q1 pdfs Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-331000
CY2020Q1 pdfs Percent Of Revenue
PercentOfRevenue
1
CY2019Q1 pdfs Percent Of Revenue
PercentOfRevenue
1
CY2020Q1 pdfs Purchase Of Treasury Stock Value In Connection With Tax Withholdings On Restricted Stock Grants
PurchaseOfTreasuryStockValueInConnectionWithTaxWithholdingsOnRestrictedStockGrants
1478000
CY2019Q1 pdfs Purchase Of Treasury Stock Value In Connection With Tax Withholdings On Restricted Stock Grants
PurchaseOfTreasuryStockValueInConnectionWithTaxWithholdingsOnRestrictedStockGrants
557000
CY2020Q1 pdfs Shortterm And Variable Lease Cost
ShorttermAndVariableLeaseCost
147000
CY2019Q1 pdfs Shortterm And Variable Lease Cost
ShorttermAndVariableLeaseCost
111000
CY2020Q1 pdfs Unbilled Receivables Not Expected To Be Billed And Collected In Next Twelve Months
UnbilledReceivablesNotExpectedToBeBilledAndCollectedInNextTwelveMonths
2800000
CY2020Q1 pdfs Unbilled Receivables Not Expected To Be Billed And Collected In Next Twelve Months
UnbilledReceivablesNotExpectedToBeBilledAndCollectedInNextTwelveMonths
4100000
CY2020Q1 pdfs Unrecognized Tax Benefits In Deferred Tax Asset Subject To Full Valuation Allowance
UnrecognizedTaxBenefitsInDeferredTaxAssetSubjectToFullValuationAllowance
5600000
CY2020Q1 pdfs Unrecognized Tax Benefits In Deferred Tax Assets
UnrecognizedTaxBenefitsInDeferredTaxAssets
11200000
CY2020Q1 pdfs Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued In Long Term Liabilities
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedInLongTermLiabilities
800000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4828000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7636000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37363000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40651000
CY2020Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
4884000
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5368000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1406000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1665000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31030000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29420000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1646000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1480000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
329681000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
325197000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3513000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3469000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3368000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3476000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
154000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
213000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1216000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1749000
CY2020Q1 us-gaap Assets
Assets
239357000
CY2019Q4 us-gaap Assets
Assets
239544000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
149376000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
147576000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2020Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1630000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
796000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1284000
CY2020Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
124000
CY2019Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
105000
CY2020Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2019Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97605000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96089000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100385000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90415000
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2780000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5674000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00015
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00015
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42182000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41797000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32795000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32503000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
5000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-694000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2743000
CY2020Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
17700000
CY2019Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
16600000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12326000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10639000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2346000
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4600000
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3300000
CY2020Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
700000
CY2019Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
500000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8487000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7867000
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
25085000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
25327000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
45000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2054000
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10000000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10500000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1700000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1300000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1667000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1292000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-25000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
8000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.87
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.04
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4754000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5072000
CY2020Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
128000
CY2019Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21586000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21269000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1340000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
952000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
747000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
886000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
886000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1093000
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27490000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27490000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5904000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1954000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6221000
CY2020Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P6Y
CY2020Q1 us-gaap Goodwill
Goodwill
2293000
CY2019Q4 us-gaap Goodwill
Goodwill
2293000
CY2020Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4007000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2789000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3479000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-98000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
968000
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
462000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
163000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
198000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3348000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1641000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-589000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
585000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
972000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
429000
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-271000
CY2019Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-472000
CY2020Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-3400000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1906000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
285000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1910000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
402000
CY2020Q1 us-gaap Lease Cost
LeaseCost
602000
CY2019Q1 us-gaap Lease Cost
LeaseCost
581000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11081000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3789000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1070000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1350000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1567000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1776000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1529000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1817000
CY2020Q1 us-gaap Liabilities
Liabilities
40888000
CY2019Q4 us-gaap Liabilities
Liabilities
43387000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
239357000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
239544000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
27064000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27996000
CY2020Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-507000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3174000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2068000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2357000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5380000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-151000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-528000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2691000
CY2020Q1 us-gaap Noncurrent Assets
NoncurrentAssets
48377000
CY2019Q4 us-gaap Noncurrent Assets
NoncurrentAssets
48407000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6000
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
455000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
470000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
9264000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1867000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7310000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7677000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
397000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
276000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7368000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7609000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0525
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0525
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y14D
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y73D
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8322000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9720000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-166000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-52000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3917000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1478000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
557000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2068000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2357000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00015
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00015
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11628000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9320000
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Reclassification&nbsp;of Prior Period Amounts</div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">Certain prior period amounts have been reclassified to conform to the current year presentation of reporting amortization of costs capitalized to obtain revenue contracts, operating lease right-of-use assets, and operating lease liabilities&nbsp;on the&nbsp;Condensed Consolidated Statements of Cash Flows. This reclassification had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on the Company&#x2019;s reported net loss or net cash used in operating activities.</div></div></div></div>
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
161000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
518000
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
810000
CY2019Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
782000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72039000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
70218000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41009000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40798000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-60000
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2020Q1 us-gaap Purchase Obligation
PurchaseObligation
12800000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8590000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8246000
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
CY2019Q1 us-gaap Restructuring Charges
RestructuringCharges
92000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36398000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35870000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21158000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
20541000
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
68500000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
333000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7895000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7011000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3368000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3476000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
562000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.10
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
9000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.21
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1566
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
745000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
726000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.64
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.84
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1560000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
713000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.79
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.68
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.86
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.66
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.76
CY2020Q1 us-gaap Share Price
SharePrice
11.72
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1484000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y65D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y160D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y127D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
100000
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
21000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
810000
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
782000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
161000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
518000
CY2020Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
15200000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
198469000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
196157000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
199795000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
197347000
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
9387000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
9294000
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
93173000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
91695000
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3917000
CY2020Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
9400000
CY2019Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
7400000
CY2020Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
CY2019Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2000
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13000000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13600000
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
2600000
CY2020Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
7400000
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
7900000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates&nbsp;</div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include revenue recognition, impairment of goodwill and long-lived assets, accounting for stock-based compensation expense, and income taxes. Actual results could differ from those estimates.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">The global COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic has impacted the operations and purchasing decisions of companies worldwide. It also has created and <div style="display: inline; font-style: italic; font: inherit;"> may </div>continue to create significant uncertainty in the global economy. The Company has undertaken measures to protect its employees, partners, customers, and vendors. In addition, the Company&#x2019;s personnel worldwide are subject to various travel restrictions, which limit the ability of the Company to provide services to customers and affiliates. This impacts the Company's normal operations. To date, the Company has been able to provide uninterrupted access to its products and services due to its globally distributed workforce, many of whom are working remotely, and its pre-existing infrastructure that supports secure access to the Company&#x2019;s internal systems. If, however, the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic has a substantial impact on the productivity of the Company&#x2019;s employees or its partners&#x2019; or customers&#x2019; decision to use the Company&#x2019;s products and services, the results of the Company&#x2019;s operations and overall financial performance <div style="display: inline; font-style: italic; font: inherit;"> may </div>be adversely impacted. The duration and extent of the impact from the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic depends on future developments that cannot be accurately predicted at this time. As of the date of issuance of the financial statements, the Company is <div style="display: inline; font-style: italic; font: inherit;">not</div> aware of any specific event or circumstance that would require updates to the Company&#x2019;s estimates and judgments or revisions to the carrying value of its assets or liabilities. These estimates <div style="display: inline; font-style: italic; font: inherit;"> may </div>change, as new events occur and additional information is obtained, and are recognized in the c&#xfeff;ondensed c&#xfeff;&#xfeff;onsolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences <div style="display: inline; font-style: italic; font: inherit;"> may </div>be material to the financial statements.</div></div></div></div>
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32703000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32485000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32703000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32485000

Files In Submission

Name View Source Status
0001437749-20-009856-index-headers.html Edgar Link pending
0001437749-20-009856-index.html Edgar Link pending
0001437749-20-009856.txt Edgar Link pending
0001437749-20-009856-xbrl.zip Edgar Link pending
ex_179295.htm Edgar Link pending
ex_179296.htm Edgar Link pending
ex_179297.htm Edgar Link pending
ex_179298.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pdfs-20200331.xml Edgar Link completed
pdfs-20200331.xsd Edgar Link pending
pdfs-20200331_cal.xml Edgar Link unprocessable
pdfs-20200331_def.xml Edgar Link unprocessable
pdfs-20200331_lab.xml Edgar Link unprocessable
pdfs-20200331_pre.xml Edgar Link unprocessable
pdfs20200331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending